首页 > 抗体蛋白 > 抗体
Brilliant Violet 605™ anti-mouse Ly-6C Antib
产品名称:
Brilliant Violet 605™ anti-mouse Ly-6C Antib
产品类别:
抗体
产品编号:
128035
产品应用:
128035
[价格]
规格 价格 库存
125µL ¥ 2508 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605? under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605? excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605? is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet?.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  2. Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
  3. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  4. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  5. Alkhani A, et al. 2020. Sci Rep. 10:7165. PubMed
  6. Gawish R, et al. 2022. Elife. 11:. PubMed
  7. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  8. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  9. Han SJ et al. 2017. Immunity. 47(6):1154-1168 . PubMed
  10. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  11. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  12. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  13. Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
  14. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  15. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  16. Kosack L, et al. 2017. Sci Rep. 7:11289. PubMed
  17. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  18. Kedage V, et al. 2022. MAbs. 14:2040083. PubMed
  19. Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
  20. Lebratti T, et al. 2021. eLife. 10:00. PubMed
  21. Zhou Y, et al. 2020. Immunity. 52(2):357-373. PubMed
  22. Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
  23. Goggi JL, et al. 2020. Mol Imaging Biol. 22:1392. PubMed
  24. Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
  25. Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
  26. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  27. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  28. Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed
  29. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
  30. Tondini E, et al. 2022. NPJ Vaccines. 7:64. PubMed
  31. Garland KM, et al. 2021. Front Immunol. 12:753472. PubMed
  32. Hassan AO, et al. 2021. Cell Reports. 36(4):109452. PubMed
  33. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  34. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  35. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  36. Da Silva CG, et al. 2019. Theranostics. 4.878472222. PubMed
  37. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  38. Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
  39. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  40. Winkler ES, et al. 2020. Nat Immunol. 21:1327. PubMed
  41. Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
  42. Giampazolias E, et al. 2021. Cell. . PubMed
  43. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  44. Beura LK, et al. 2018. Immunity. 48:327. PubMed
  45. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  46. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  47. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  48. Lam KC, et al. 2021. Cell. 184:5338. PubMed
  49. Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
  50. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  51. Soncin I, et al. 2018. Nat Commun. 9:582. PubMed
  52. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  53. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  54. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  55. Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
  56. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  57. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  58. Sheng J, et al. 2021. eLife. 10:00. PubMed
  59. Mathur AN, et al. 2019. Immunity. 50:655. PubMed
  60. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  61. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  62. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  63. Perez-Cruz M, et al. 2021. PLoS One. e0236216:16. PubMed
  64. Young K, et al. 2021. Cell Stem Cell. . PubMed
  65. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  66. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  67. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  68. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
RRID
AB_2562352 (BioLegend Cat. No. 128035) AB_2562353 (BioLegend Cat. No. 128036)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线